Fluorescent and bioluminescent bovine H5N1 influenza viruses for evaluation of antiviral interventions
- PMID: 39387583
- PMCID: PMC11575140
- DOI: 10.1128/jvi.01385-24
Fluorescent and bioluminescent bovine H5N1 influenza viruses for evaluation of antiviral interventions
Abstract
In early 2024, a clade 2.3.4.4b high pathogenic H5N1 avian influenza virus was detected in dairy cows and humans in the United States. Since then, it has spread to herds in at least 13 states and caused symptomatic disease in at least fifteen people. To facilitate rapid testing of existing and novel countermeasures, here, we report the development of an H5N1 viral reverse genetic system, its use to produce fluorescent and bioluminescent variant strains, and their utility in high-throughput evaluation of antiviral interventions.
Keywords: NanoLuc; drug testing; influenza viruses; sfGFP.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Burrough ER, Magstadt DR, Petersen B, Timmermans SJ, Gauger PC, Zhang J, Siepker C, Mainenti M, Li G, Thompson AC, Gorden PJ, Plummer PJ, Main R. 2024. Highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b virus infection in domestic dairy cattle and cats, United States, 2024. Emerg Infect Dis 30:1335–1343. doi:10.3201/eid3007.240508 - DOI - PMC - PubMed
-
- Uyeki TM, Milton S, Abdul Hamid C, Reinoso Webb C, Presley SM, Shetty V, Rollo SN, Martinez DL, Rai S, Gonzales ER, Kniss KL, Jang Y, Frederick JC, De La Cruz JA, Liddell J, Di H, Kirby MK, Barnes JR, Davis CT. 2024. Highly pathogenic avian influenza a(H5N1) virus infection in a dairy farm worker. N Engl J Med 390:2028–2029. doi:10.1056/NEJMc2405371 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI137031/AI/NIAID NIH HHS/United States
- G20 AI167200/AI/NIAID NIH HHS/United States
- R01 AI168107/AI/NIAID NIH HHS/United States
- UC7 AI180254/AI/NIAID NIH HHS/United States
- UC6 AI058607/AI/NIAID NIH HHS/United States
- R01AI137031/HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- R01AI168107/HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- T32 CA009111/CA/NCI NIH HHS/United States
- Burroughs Wellcome Fund (BWF)
- 75N93019C00050/AI/NIAID NIH HHS/United States
- Translating Duke Health Initiative
LinkOut - more resources
Full Text Sources
Medical
